MEDIASSIST - Medi Assist Healthcare Services Limited Share Price

In the earnings conference call held on May 11, 2026, management provided an optimistic outlook for Medi Assist Healthcare Services Limited, highlighting a transformative year. CEO Satish Gidugu emphasized that FY '26 marked a milestone with significant growth and a technology-led transformation, achieving debt-free status and a net cash-positive position. The AI-powered platforms processed nearly one million claims monthly, leading to remarkable operational metrics.

Key highlights included:

• Total premium under management reached INR 25,923 crores, up 22.8% year-on-year.
• Group premiums increased to over INR 23,000 crores, growing 25.6% year-on-year with a retention rate of 93.2%.
• Retail premiums in the TPA model grew 4.2% year-on-year, amounting to INR 2,818 crores.
• The group segment's market share increased to 33.7%, and the retail segment's market share in the traditional TPA model was reported at 5%.
• Technology revenues surged 91.9% year-on-year, driven by advancements like the MAven Guard AI fraud detection platform, which prevented over INR 540 crores in health insurance fraud.

Looking forward, management expects continued growth driven by the expansion of technology solutions and partnerships in Southeast Asia. The integration of Paramount TPA is on track, with over 50% of their claims volume migrated to the MAtrix platform, aiming for full integration by Q2 FY '27. The company anticipates that technology and international growth trends will continue, and it aims to capture a higher share of the market as health insurance demand increases in India and abroad.

Q&A Section Response Summary

Question 1: How do you think Medi Assist can achieve dominance in the retail business similar to the group business?
Answer: Achieving dominance in retail requires adapting to the evolving landscape. Unlike group policies where stakeholders are more informed, retail has historically been simplistic. We're leveraging our TPA capabilities for insurers, creating hybrid products that address outpatient needs. By evolving our offerings and enhancing technology, we're improving service delivery to members, which we believe will solidify our position over time.

Question 2: Can you provide insights on the earnings generated from the technology business?
Answer: While we haven't previously detailed revenue metrics, it's reasonable to see potential margins increase to 1.5-2 times traditional TPA rates as we scale. We are also expanding internationally with our tech stack, which might boost earnings further. However, varied contract terms across markets make concrete guidance challenging. Overall, we're optimistic about this growth trajectory.

Question 3: What portion of industry premiums is administered via TPAs?
Answer: There aren't definitive figures, but it's approximately a 50-50 split between traditional TPA models and other segments. This ratio reflects our core business dynamics and regulatory factors. Many employer groups still rely heavily on TPAs, affirming the significance of this market share.

Question 4: Can you elaborate on the international segment's pricing and growth expectations?
Answer: Yes, the INR22 crore from technology is a starting point, with pricing evolving based on product mix. Despite historical dependency on traditional revenues, we're moving toward outcome-based pricing. We anticipate sustaining substantial growth, leveraging our technology to enhance our positions in international markets.

Question 5: What impact do you foresee from Bima Sugam on Medi Assist's operations?
Answer: We don't foresee any disruption from Bima Sugam in the short term. While some services may shift, our extensive network and technology integrations help ensure we remain essential. We believe the core work of health insurance"”in terms of claims management and network maintenance"”will not diminish and may create opportunities for us.

Question 6: What is the expected timeline for integrating Paramount and achieving synergies?
Answer: Historically, integrations take 4 to 5 quarters. We're three quarters in and are on track for increased synergies possibly by Q2 of FY '27. Recent margin improvements indicate we are moving in the right direction.

Question 7: What strategies will enhance organic growth in the core group business?
Answer: To grow organically by 10-12%, we are focusing on diversified industries beyond IT-ITES, which has seen slower growth recently. We're targeting sectors like chemicals and oil/gas where demand remains strong. Additionally, we continuously add new contracts to bolster growth despite economic fluctuations. There's a solid pipeline here.

Question 8: Can you address the nature of headcount-based contracts and their implications?
Answer: We utilize headcount contracts mainly in government public health schemes, providing coverage to large populations. We're integrating technology to optimize these contracts. While traditional workflows still necessitate substantial manpower, our tech advancements will reduce dependency over time, improving efficiency and margins.

Question 9: Is there any expected conflict impact on international business due to current events?
Answer: We haven't experienced direct impacts from conflicts such as in the Middle East, as our operations mainly focus on Europe and Southeast Asia. While some revenue patterns may shift, we perceive ongoing demand in the regions we serve. Evaluating each market's unique challenges remains critical for our strategy moving forward.